Expression and purification of phosphorylated and non-phosphorylated human MEK1

Protein Expression and Purification

Volumn 52, Issue 2, 2007, Pages 446-456

  Smith, Catherine K ^a   Carr, Donna ^a   Mayhood, Todd W ^a   Jin, Weihong ^a   Gray, Kimberly ^a   Windsor, William T ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Baculovirus; Circular dichroism; Kinase; MAPK; MEK1; Phosphorylation; Raf BXB

Indexed keywords

MAP2K1 PROTEIN, HUMAN; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; SERINE; UNCLASSIFIED DRUG;

ANIMAL; ARTICLE; CELL CULTURE; CHEMISTRY; CIRCULAR DICHROISM; CYTOLOGY; GENE EXPRESSION; GENETICS; HUMAN; INSECT; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELLS, CULTURED; CHROMATOGRAPHY, LIQUID; CIRCULAR DICHROISM; GENE EXPRESSION; HUMANS; INSECTS; MAP KINASE KINASE 1; MASS SPECTROMETRY; PHOSPHORYLATION; SERINE;

EID: 33846415054     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2006.11.002     Document Type: Article

References (31)

1. Pearson G., Robinson F., Beers-Gibson T., Xu B., Karandikar M., Berman K., and Cobb M.H. Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr. Rev. 22 (2001) 153-183
2. Sebolt-Leopold J.S. Development of anticancer drugs targeting the MAP kinase pathway. Oncogene 19 (2000) 6594-6599
3. English J., and Cobb M. Pharmacological inhibitors of MAPK pathways. Trends Pharmacol. Sci. 23 (2002) 40-45
4. Anderson N.G., Maller J.L., Tonks N.K., and Sturgill T.W. Requirement for integration of signals from two distinct phosphorylation pathways for activation of MAP kinase. Nature 343 (1990) 651-653
5. Alessi D.R., Saito Y., Campbell D.G., Cohen P., Sithanandam G., Rapp U., Ashworth A., Marshall C.J., and Cowley S. Identification of the sites in MAP kinase kinase-1 phosphorylated by p74raf-1. EMBO J. 13 (1994) 1610-1619
6. Ohren J.F., Chen H., Pavlovsky A., Whitehead C., Zhang E., Kuffa P., Yan C., McConnell P., Spessard C., Banotai C., Mueller W.T., Delaney A., Omer C., Sebolt-Leopold J., Dudley D.T., Leung I.K., Flamme C., Warmus J., Kaufman M., Barrett S., Tecle H., and Hasemann C.A. Structures of human MAP kinase kinase 1 (MEK1) and MEK2 describe novel noncompetitive kinase inhibition. Nat. Struct. Mol. Biol. 11 (2004) 1192-1197
7. Resing K.A., Mansour S.J., Hermann A.S., Johnson R.S., Candia J.M., Fukasawa K., Vande Woude G.F., and Ahn N.G. Determination of v-Mos-catalyzed phosphorylation sites and autophosphorylation sites on MAP kinase kinase by ESI/MS. Biochemistry 34 (1995) 2610-2620
8. Nebreda A.R., Hill C., Gomez N., Cohen P., and Hunt T. The protein kinase mos activates MAP kinase kinase in vitro and stimulates the MAP kinase pathway in mammalian somatic cells in vivo. FEBS Lett. 333 (1993) 183-187
9. Posada J., Yew N., Ahn N.G., Woude G.F.V., and Cooper J.A. Mos stimulates MAP kinase in Xenopus oocytes and activates a MAP kinase kinase in vitro. Mol. Cell. Biol. 13 (1993) 2546-2553
10. Lange-Carter C.A., Pleiman C.M., Gardner A.M., Blumer K.J., and Johnson G.L. A divergence in the MAP kinase regulatory network defined by MEK kinase and Raf. Science 260 (1993) 315-319
11. Kyriakis J.M., App H., Zhang X.F., Banerjee P., Brautigan D.L., Rapp U.R., and Avruch J. Raf-1 activates MAP kinase-kinase. Nature 358 (1992) 417-421
12. Morrison D.K., and Cutler R.E. The complexity of Raf-1 regulation. Curr. Opin. Cell Biol. 9 (1997) 174-179
13. Bruder J.T., Heidecker G., and Rapp U.R. Serum-, TPA-, and Ras-induced expression from Ap-1/Ets-driven promoters requires Raf-1 kinase. Genes & Dev. 6 (1992) 545-556
14. Dent P., Chow Y.H., Wu J., Morrison D.K., Jove R., and Sturgill T.W. Expression, purification and characterization of recombinant mitogen-activated protein kinase kinases. Biochem J. 303 (1994) 105-112
15. Mansour S.J., Matten W.T., Hermann A.S., Candia J.M., Rong S., Fukasawa K., Vande Woude G.F., and Ahn N.G. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science 265 (1994) 966-970
16. Her J.H., Lakhani S., Zu K., Vila J., Dent P., Sturgill T.W., and Weber M.J. Dual phosphorylation and autophosphorylation in mitogen-activated protein (MAP) kinase activation. J. Biochem. (Tokyo) 296 (1993) 25-31
17. Robbins D.J., Zhen E., Owaki H., Vanderbilt C.A., Ebert D., Geppert T.D., and Cobb M.H. Regulation and properties of extracellular signal-regulated protein kinases 1 and 2 in vitro. J. Biol. Chem. 268 (1993) 5097-5106
18. Waldron T.T., and Murphy K.P. Stabilization of proteins by ligand binding: application to drug screening and determination of unfolding energetics. Biochemistry 42 (2003) 5058-5064
19. Brandts J.F., and Lin L.N. Study of strong to ultratight protein interactions using differential scanning calorimetry. Biochemistry 29 (1990) 6927-6940
20. Mayhood T.W., and Windsor W.T. Ligand binding affinity determined by temperature-dependent circular dichroism: cyclin-dependent kinase 2 inhibitors. Anal. Biochem. 345 (2005) 187-197
21. Cohen P., Holmes C.F., and Tsukitani Y. Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem. Sci. 15 (1990) 98-102
22. Brautigan D.L., Chen J., and Thompson P. Protein phosphatase 2A: Specificity with physiological substrates and inactivation by tyrosine phosphorylation in. Adv. Protien Phosphatases (1993) 49-65
23. Pei J.J., Gong C.X., An W.L., Winblad B., Cowburn R.F., Grundke-Iqbal I., and Iqbal K. Okadaic-acid-induced inhibition of protein phosphatase 2A produces activation of mitogen-activated protein kinases ERK1/2, MEK1/2, and p70 S6 similar to that in Alzheimer's disease. Am. J. Path. 163 (2003) 845-858
24. Frost J.A., Steen H., Shapiro P., Lewis T., Ahn N., Shaw P.E., and Cobb M.H. Cross-cascade activation of ERKs and ternary complex factors by Rho family proteins. EMBO J. 16 (1997) 6426-6438
25. Eblen S.T., Slack-Davis J.K., Tarcsafalvi A., Parsons J.T., Weber M.J., and Catling A.D. Mitogen-activated protein kinase feedback phosphorylation regulates MEK1 complex formation and activation during cellular adhesion. Mol. Cell. Biol. 24 (2004) 2308-2317
26. Favata M.F., Horiuchi K.Y., Manos E.J., Daulerio A.J., Stradley D.A., Feeser W.S., Van-Dyk D.E., Pitts W.J., Earl R.A., Hobbs F., Copeland R.A., Magolda R.L., Scherle P.A., and Trzaskos J.M. Identification of a novel inhibitor of mitogen-activated protein kinase kinase. J. Biol. Chem. 273 (1998) 18623-18632
27. Sebolt-Leopold J.S., and Herrera R. Targeting the mitogen-activated protein kinase cascade to treat cancer. Nat. Rev. Cancer 12 (2004) 937-947
28. Morrison D.K., and Davis R.J. Regulation of MAP kinase signaling modules by scaffold proteins in mammals. Annu. Rev. Cell Dev. Biol. 19 (2003) 91-118
29. Roy F., Laberge G., Douziech M., Ferland-McCollough D., and Therrien M. KSR is a scaffold required for activation of the ERK/MAPK module. Genes Dev. 16 (2002) 427-438
30. Luttrell L.M., Roudabush F.L., Choy E.W., Miller W.E., Field M.E., Pierce K.L., and Lefkowitz R.J. Activation and targeting of extracellular signal-regulated kinases by beta-arrestin scaffolds. Proc. Natl. Acad. Sci. USA 98 (2001) 2449-2454
31. Schaeffer H.J., Catling A.D., Eblen S.T., Collier L.S., Krauss A., and Weber M.J. MP1: a MEK binding partner that enhances enzymatic activation of the MAP kinase cascade. Science 281 (1998) 1668-1671